JP2020533276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533276A5 JP2020533276A5 JP2020505478A JP2020505478A JP2020533276A5 JP 2020533276 A5 JP2020533276 A5 JP 2020533276A5 JP 2020505478 A JP2020505478 A JP 2020505478A JP 2020505478 A JP2020505478 A JP 2020505478A JP 2020533276 A5 JP2020533276 A5 JP 2020533276A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- raav vector
- nucleic acid
- aav
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762540053P | 2017-08-01 | 2017-08-01 | |
| US62/540,053 | 2017-08-01 | ||
| US201762583890P | 2017-11-09 | 2017-11-09 | |
| US62/583,890 | 2017-11-09 | ||
| US201762596535P | 2017-12-08 | 2017-12-08 | |
| US201762596670P | 2017-12-08 | 2017-12-08 | |
| US62/596,670 | 2017-12-08 | ||
| US62/596,535 | 2017-12-08 | ||
| PCT/US2018/044892 WO2019028192A1 (en) | 2017-08-01 | 2018-08-01 | METHODS OF GENE THERAPY TARGETING FACTOR VIII (FVIII) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020533276A JP2020533276A (ja) | 2020-11-19 |
| JP2020533276A5 true JP2020533276A5 (OSRAM) | 2021-11-25 |
| JP7499174B2 JP7499174B2 (ja) | 2024-06-13 |
Family
ID=65234171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505478A Active JP7499174B2 (ja) | 2017-08-01 | 2018-08-01 | 第ｖｉｉｉ因子（ｆｖｉｉｉ）遺伝子治療法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20200237930A1 (OSRAM) |
| EP (1) | EP3661541A4 (OSRAM) |
| JP (1) | JP7499174B2 (OSRAM) |
| KR (2) | KR20200066289A (OSRAM) |
| CN (1) | CN111163796A (OSRAM) |
| AU (2) | AU2018312565A1 (OSRAM) |
| BR (1) | BR112020001979A2 (OSRAM) |
| CA (1) | CA3071519A1 (OSRAM) |
| CL (1) | CL2020000295A1 (OSRAM) |
| CO (1) | CO2020002283A2 (OSRAM) |
| IL (1) | IL272373A (OSRAM) |
| MX (1) | MX2020001402A (OSRAM) |
| MY (1) | MY208862A (OSRAM) |
| PE (1) | PE20200722A1 (OSRAM) |
| PH (1) | PH12020500239A1 (OSRAM) |
| SG (1) | SG11202000650YA (OSRAM) |
| WO (1) | WO2019028192A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| PE20231949A1 (es) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
| JP2021509812A (ja) | 2018-01-05 | 2021-04-08 | プレートレット バイオジェネシス， インコーポレイテッド | 巨核球を産生するための組成物および方法 |
| WO2020006539A1 (en) | 2018-06-29 | 2020-01-02 | Platelet Biogenesis, Inc. | Compositions for drug delivery and methods of use thereof |
| AU2019314513A1 (en) * | 2018-08-03 | 2021-01-28 | Sangamo Therapeutics, Inc. | Improved clinical parameters by expression of factor viii |
| EP3923992A1 (en) | 2019-02-15 | 2021-12-22 | CRISPR Therapeutics AG | Gene editing for hemophilia a with improved factor viii expression |
| MX2021011039A (es) * | 2019-03-13 | 2021-12-15 | Generation Bio Co | Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con fviii. |
| CN110684798A (zh) * | 2019-09-03 | 2020-01-14 | 深圳新诺微环生物科技有限公司 | 肌肉靶向的微环dna基因治疗 |
| JP2023501262A (ja) * | 2019-11-01 | 2023-01-18 | フリーライン セラピューティクス リミテッド | 転写調節エレメント |
| WO2021113800A1 (en) * | 2019-12-06 | 2021-06-10 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating factor viii function |
| CN114989307B (zh) * | 2022-05-11 | 2023-08-01 | 华兰生物工程股份有限公司 | 一种重组人凝血因子Ⅷ-Fc融合蛋白及制备方法 |
| CN115948408A (zh) * | 2022-09-23 | 2023-04-11 | 上海信致医药科技有限公司 | 改进的人凝血因子viii基因表达盒及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6818439B1 (en) * | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
| EP1224312A1 (en) * | 1999-10-12 | 2002-07-24 | The University of North Carolina at Chapel Hill | Adeno-associated virus vectors encoding factor viii and methods of using the same |
| AU2014318890B2 (en) * | 2013-09-12 | 2019-03-07 | Biomarin Pharmaceutical Inc. | Adeno-associated virus Factor VIII vectors |
| ES2993915T3 (en) * | 2014-08-13 | 2025-01-13 | Childrens Hospital Philadelphia | An improved expression cassette for packaging and expression of variant factor viii for the treatment of hemostasis disorders |
| CN108093639B (zh) * | 2015-04-16 | 2022-07-19 | 埃默里大学 | 用于肝脏中蛋白质表达的重组启动子和载体及其用途 |
| TWI841908B (zh) * | 2015-09-24 | 2024-05-11 | 美商拜奧馬林製藥公司 | 腺相關病毒因子viii載體、相關病毒粒子及包含其之治療調配物 |
| AU2016343887B2 (en) * | 2015-10-28 | 2023-04-06 | Sangamo Therapeutics, Inc. | Liver-specific constructs, factor VIII expression cassettes and methods of use thereof |
| PE20231949A1 (es) * | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
| US20190144524A1 (en) * | 2016-01-14 | 2019-05-16 | The Children's Hospital Of Philadelphia | Factor viii variants, nucleic acid sequences, and methods and uses for treatment of hemostasis disorders |
-
2018
- 2018-08-01 CA CA3071519A patent/CA3071519A1/en active Pending
- 2018-08-01 PE PE2020000180A patent/PE20200722A1/es unknown
- 2018-08-01 JP JP2020505478A patent/JP7499174B2/ja active Active
- 2018-08-01 WO PCT/US2018/044892 patent/WO2019028192A1/en not_active Ceased
- 2018-08-01 BR BR112020001979-8A patent/BR112020001979A2/pt unknown
- 2018-08-01 KR KR1020207005859A patent/KR20200066289A/ko not_active Ceased
- 2018-08-01 MY MYPI2020000557A patent/MY208862A/en unknown
- 2018-08-01 EP EP18840279.6A patent/EP3661541A4/en active Pending
- 2018-08-01 KR KR1020247034886A patent/KR20240160648A/ko active Pending
- 2018-08-01 SG SG11202000650YA patent/SG11202000650YA/en unknown
- 2018-08-01 US US16/635,957 patent/US20200237930A1/en not_active Abandoned
- 2018-08-01 MX MX2020001402A patent/MX2020001402A/es unknown
- 2018-08-01 CN CN201880064058.9A patent/CN111163796A/zh active Pending
- 2018-08-01 AU AU2018312565A patent/AU2018312565A1/en not_active Abandoned
-
2020
- 2020-01-30 IL IL272373A patent/IL272373A/en unknown
- 2020-01-31 PH PH12020500239A patent/PH12020500239A1/en unknown
- 2020-01-31 CL CL2020000295A patent/CL2020000295A1/es unknown
- 2020-02-28 CO CONC2020/0002283A patent/CO2020002283A2/es unknown
-
2024
- 2024-09-03 AU AU2024219336A patent/AU2024219336A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533276A5 (OSRAM) | ||
| RU2018119710A (ru) | Кодирующие фактор viii варианты с пониженным содержанием cpg, композиции и способы, и применение в лечении нарушений гемостаза | |
| JP2021003120A5 (OSRAM) | ||
| JP7493566B2 (ja) | 筋ジストロフィーを治療するためのマイクロジストロフィン断片のアデノ随伴ウイルスベクター送達 | |
| JP2019503649A5 (OSRAM) | ||
| JP2024009857A5 (OSRAM) | ||
| JP2021087431A5 (OSRAM) | ||
| JP2019116492A5 (OSRAM) | ||
| JP2018506261A5 (OSRAM) | ||
| JP2021106619A5 (OSRAM) | ||
| CN118895311A (zh) | 腺相关病毒载体传递微肌营养不良蛋白以治疗肌营养不良症 | |
| JP2018522529A5 (OSRAM) | ||
| TW201840850A (zh) | 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症 | |
| JP2020522269A5 (OSRAM) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| JP2018531609A5 (OSRAM) | ||
| RU2018116076A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
| US20210198692A1 (en) | Adeno-associated viral vector-mediated gene therapy for treating fragile x-associated disorders | |
| US20040002159A1 (en) | Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof | |
| JP2017529395A5 (OSRAM) | ||
| JPWO2020041773A5 (OSRAM) | ||
| JPWO2020186150A5 (OSRAM) | ||
| JPWO2020186207A5 (OSRAM) | ||
| RU2020108209A (ru) | Способы генотерапии с использованием гена фактора viii (fviii) | |
| NZ741860B2 (en) | Cpg reduced factor viii variants, compositions and methods and uses for treatment of hemostasis disorders |